Socioeconomic determinants of outpatient antibiotic use in Europe

International Journal of Public Health

Volumn 55, Issue 5, 2010, Pages 469-478

  Masiero, Giuliano ^a   Filippini, Massimo ^a,b   Ferech, Matus ^c,d   Goossens, Herman ^c  

^a UNIVERSITY OF LUGANO   (Switzerland)

^b ETH ZURICH   (Switzerland)

^c UNIVERSITY OF ANTWERP   (Belgium)

^d EUROPEAN COMMISSION   (Belgium)

Author keywords

Antibiotic use; Bacterial resistance; Cross country variations; Socioeconomic inequalities

Indexed keywords

ANTIINFECTIVE AGENT;

ANTIBIOTIC RESISTANCE; ARTICLE; CLINICAL PRACTICE; ECONOMICS; EUROPE; HEALTH CARE DELIVERY; HUMAN; OUTPATIENT; PROSPECTIVE PAYMENT; SOCIAL CLASS; STATISTICAL MODEL; STATISTICS;

ANTI-BACTERIAL AGENTS; DRUG RESISTANCE, BACTERIAL; EUROPE; HEALTH SERVICES ACCESSIBILITY; HUMANS; MODELS, ECONOMETRIC; OUTPATIENTS; PHYSICIAN'S PRACTICE PATTERNS; PROSPECTIVE PAYMENT SYSTEM; SOCIAL CLASS;

EID: 77958044458     PISSN: 16618556     EISSN: 1420911X     Source Type: Journal    
DOI: 10.1007/s00038-010-0167-y     Document Type: Article

References (41)

1. W Albrich D Monnet S Harbarth 2004 Antibiotic selection pressure and resistance in Streptococcus pneumoniae and Streptococcus pyogenes Emerg Infect Dis 10 514 517 15109426
2. DJ Austin KG Kristinsson RM Anderson 1999 The relationship between the volume of antimicrobial consumption in human communities and the frequency of resistance Proc Natl Acad Sci USA 96 1152 1156 1:CAS:528:DyaK1MXpvFansw%3D%3D 10.1073/pnas.96.3.1152 9927709
3. Baltagi BH (2005) Econometric analysis of panel data. Wiley, Chichester, West Sussex
4. MR Baye R Maness SN Wiggins 1997 Demand systems and the true subindex of the cost of living for pharmaceuticals Appl Econ 29 1179 1189 10.1080/00036849700000009
5. EA Belongia B Schwartz 1998 Strategies for promoting judicious use of antibiotics by doctors and patients Brit Med J 317 668 671 1:STN:280: DyaK1czpslarug%3D%3D 9728003
6. M Bergman S Huikko M Pihlajama P Laippala E Palva P Huovinen H Seppala 2004 Effect of macrolide consumption on erythromycin resistance in Streptococcus pyogenes in Finland in 1997-2001 Clin Infect Dis 38 1251 1256 1:CAS:528:DC%2BD2cXksFers7g%3D 10.1086/383309 15127336
7. C Butler 2008 Sustainable health for all by the year 2100? Int J Public Health 53 223 224 10.1007/s00038-008-8080-3 18820831
8. Cameron AC, Trivedi PK (2005) Microeconometrics. Cambridge University Press, New York
9. J Cockburn S Pit 1997 Prescribing behaviour in clinical practice: patients' expectations and doctors' perceptions of patients' expectations-a questionnaire study Brit Med J 315 520 523 1:STN:280:DyaK2svmvFyqsw%3D%3D 9329308
10. L Di Matteo 2005 The macro determinants of health expenditure in the United States and Canada: assessing the impact of income, age distribution and time Health Policy 71 23 42 10.1016/j.healthpol.2004.05.007 15563991
11. L Di Matteo P Grootendorst 2002 Federal patent extension, provincial policies, and drug expenditures, 1975-2000 Can Tax J 50 1913 1948
12. Dickson M, Jacobzone S (2003) Pharmaceutical use and expenditure for cardiovascular disease and stroke: a study of 12 OECD countries. OECD Health Working Papers 1
13. Donaldson C, Gerard K, Mitton C, Jan S, Wiseman V (2004) Economics of health care financing: the visible hand. Thomas Palgrave MacMillan, London
14. EH Elbasha 2003 Deadweight loss of bacterial resistance due to overtreatment Health Econ 12 125 138 10.1002/hec.702 12563660
15. SF Ellison I Cockburn Z Griliches J Hausman 1996 Characteristics of demand for pharmaceutical products: an examination of four cephalosporins Rand J Econ 28 426 446 10.2307/2556023
16. M Elsevier M Ferech RH Vander Stichele H Goossens 2007 Antibiotic use in ambulatory care in Europe (ESAC data 1997-2002): trends, regional differences and seasonal fluctuations Pharmacoepidem Dr S 16 115 123 10.1002/pds.1244
17. European Antimicrobial Resistance Surveillance System (2007) EARSS interactive database. http://www.rivm.nl/earss/database. Accessed December 2007
18. European Observatory on Health Systems and Policies (2007) Health system profiles (HiTs). http://www.euro.who.int/en/home/projects/observatory/ publications/health-system-profiles-hits. Accessed December 2007
19. Eurostat (2007) Eurostat statistics. http://epp.eurostat.ec.europa.eu/ portal/page/portal/statistics/ themes. Accessed December 2007
20. M Filippini G Masiero K Moschetti 2006 Socioeconomic determinants of regional differences in outpatient antibiotic consumption: evidence from Switzerland Health Policy 78 77 92 10.1016/j.healthpol.2005.09.009 16290129
21. M Filippini G Masiero K Moschetti 2009 Small area variations and welfare loss in the use of outpatient antibiotics Health Econ Pol Law 4 55 77 10.1017/S174413310800460X
22. M Filippini G Masiero K Moschetti 2009 Regional consumption of antibiotics: a demand system approach Econ Model 26 1389 1397 10.1016/j.econmod.2009.07.007
23. RG Finch JP Metlay PG Davey LL Baker 2004 Educational interventions to improve antibiotic use in the community: report from the international forum on antibiotic resistance (IFAR) colloquium Lancet 4 44 53 10.1016/S1473-3099(03) 00860-0
24. H Goossens M Ferech R Vander Stichele M Elseviers 2005 Outpatient antibiotic use in Europe and association with resistance: a cross-national database study Lancet 365 579 587 15708101
25. Greene WH (2003) Econometric analysis. Prentice Hall, New York
26. J Habicht RA Kiivet T Habicht AE Kunst 2009 Social inequalities in the use of health care services after 8 years of health care reforms-a comparative study of the Baltic countries Int J Public Health 54 250 259 10.1007/s00038-009-8012-x 19183845
27. E Hoogendijk MB van Groenou T van Tilburg D Deeg 2008 Educational differences in functional limitations: comparison of 55-65-years-olds in the Netherlands in 1992 and 2002 Int J Public Health 53 281 289 19112590
28. J Hunt-McCool BF Kiker YC Ng 1994 Estimates of the demand for medical care under different functional forms J Appl Econ 9 201 218 10.1002/jae. 3950090206
29. B Huttner H Goossens T Verheij S Harbarth 2010 Characteristics and outcomes of public campaigns aimed at improving the use of antibiotics in outpatients in high-income countries Lancet Infect Dis 10 17 31 10.1016/S1473-3099(09)70305-6 20129146
30. İÖ İlhan F YIldIrIm H Demisbaş YB Doǧan 2009 Prevalence and sociodemographic correlates of substance use in a university-student sample in Turkey Int J Public Health 54 40 44 10.1007/s00038-009-7049-1 19142577
31. AE Kunst 2009 Socioeconomic inequalities in health in Central and Eastern Europe: synthesis of results of eight new studies Int J Public Health 54 197 200 10.1007/s00038-009-9010-8 19652911
32. M Matuz R Benko P Doro E Hajdu G Nagy E Nagy DL Monnet G Soos 2006 Regional variations in community consumption of antibiotics in Hungary, 1996-2003 Br J Clin Pharmacol 61 96 100 10.1111/j.1365-2125.2005.02525.x 16390356
33. JE McGowan 2001 Economic impact of antimicrobial resistance Emerg Infect Dis 7 286 292 10.3201/eid0702.010228 11294725
34. OECD (2007) OECD Health Data 2007. http://titania.sourceoecd.org/vl= 1037283/cl=48/nw=1/rpsv/statistic/s37-about.htm?jnlissn=99991012. Accessed December 2007
35. M Richter CA Vereecken W Boyce L Maes SN Gabhainn CE Currie 2009 Parental occupation, family affluence and adolescent health behavior in 28 countries Int J Public Health 54 203 212 10.1007/s00038-009-8018-4 19347249
36. N Rudholm 2002 Economic implications of antibiotic resistance in a global economy J Health Econ 21 1071 1083 10.1016/S0167-6296(02)00053-X 12475126
37. J Stephenson 1996 Icelandic researchers are showing the way to bring down rates of antibiotic-resistant bacteria JAMA-J Am Med Assoc 275 175 1:STN:280:DyaK287ptVequw%3D%3D 10.1001/jama.275.3.175
38. Swiss National Science Foundation (2007) National Research Programme NRP 49 Antibiotic Resistance Final Report. http://www.nrp49.ch/upload/docs/ Dokumente/NRP-49-Report-WEB%20mit%20Links.pdf. Accessed December 2007
39. Thomas RL (1987) Applied demand analysis. Longman, London
40. R Vander Stichele M Elseviers M Ferech S Blot H Goossens 2004 European surveillance of antimicrobial consumption (ESAC): data collection performance and methodological approach Br J Clin Pharmacol 58 419 428 1:STN:280: DC%2BD2cvmsVGnug%3D%3D 10.1111/j.1365-2125.2004.02164.x 15373935
41. M Woodhead F Blasi S Ewig G Huchon M Leven A Ortqvist T Schaberg A Torres G van der Heijden TJM Verheij 2005 Guidelines for the management of adult lower respiratory tract infections Eur Respir J 26 1138 1180 1:STN:280: DC%2BD2MnjvVWmtA%3D%3D 10.1183/09031936.05.00055705 16319346